Anavex Life Sciences Corp (AVXL)

[WilliamMunny]

Steady (or anyone else), if "TLD data is not material UNLESS it shows a clear trial failure," how was Biogen able to release its Lecanemab data in contravention of the CTAD embargo? The trial was certainly not a clear failure, and they obviously got an exemption to the embargo. That exemption is for publicly traded companies whose counsel can successfully argue to CTAD that withholding the data from release would contravene SEC regulations.